Szemészet, 2020 (157. évfolyam, 1-4. szám)

2020-09-01 / 3. szám

Vasculitisek szemészeti

vonatkozásai - Retinalis

vasculitisek

23. Rowley

AH,

Stanford

T.

Shulman.

Kawasaki Syndrome. Clin Microbiol

Rev

1998 Jul; 11(31:405-414.

24. Hernandez

J, et al. Diagnosis

and classification of polyarteritis nodosa.

J

of Autoimmun 2014;

48-49: 84-89.

25. Hara

A, et

al.

Microscopic polyangiitis with ocular manifestations as the initial presenting sign. Am J Med Sei

2007;

334(4): 308-10.

26. Coutu

RE, et al. Limited form of Wegener's granulomatosis. Eye involvement as a major sign. JAMA 1975; 233: 868-71.

27. Ahmed

M, et al. Diagnosis of limited ophthalmic Wegener's granulomatosis: Distinctive features with ANCA test confirmation. Int

Ophthalmol

2008; 28: 35-46.

28. Tervaert

JW, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990 Sep 22; 336(8717): 709-11.

29. Tarabishy

AB, et al. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010; 55(5): 429-44.

30. Kubaisi

B, et al. Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. Intractable Rare Dis Res 2016; 5(2): 61-69.

31. Chan-Bum

Choi, et al. Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients. Yonsei Med J 2019; 60(8): 705-712. Published online 2019 Jul 19. doi: 10.3349/ymj.2019.60.8.705

32. Furuta

Sh, et al. Update on eosinophilic granulomatosis with polyangiitis An Invited Review Article. Allergol Int

2019;

68(4): 430-436.

33. Akella

S,

et al. Ophthalmic Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome): A Systematic Review of the Literature. Opht Plastic and Reconstr Surg 2019; 35(1): 7-16.

34. Fernando

Arevalo J, et al. Ocular manifestations of systemic lupus erythematosus. CurrOpin Ophthalmol 2002; 13(6): 404-10.

35. Radic

M, et al. Vascular manifestations of systemic lupus erythematosus - A Review. The Netherlands J of Medicine 2013; 71(1): 1-16.

36. Butendieck

RR, et al. Systemic Lupus Erythematosus-associated Retinal Vasculitis. The J of Rheumatol 2012; 39(5): 1095-1096.

37. Au

A, et al. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exp Ophthalmol 2004; 32(1): 87-100.

38. Kiss

E és

Dohán J.

Egy

ritkán felismert ritka betegség: a Behcet-kór/Behcet's disease: a hardly diagnosed orphan disorder. Orvosi

Hetilap 2013; 154 (3): 93-101. https://doi.org/10.1556/0H.2013.29528

39. Dohán

J és Magyar M. A Behcet-szindróma szemészeti tünetei/Ocular ma

nifestations of Behcet disease. Szemészet

2019;

3: 201-207.

40. Susac

JO, et al. Microangiopathy of the brain and retina. Neurology 1979; 29(3): 313-6.

41. Susac

JO, et al. MRI-findings in Susac's syndrome. Neurology 2003; 61(12): 1783-7.

42. Magr

MC,

et

al. Susac syndrome An organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol 2011; 136: 903-912.

43. Cogan

DG. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 1945; 33:144-9.

44. D

’Aguanno V, et al. Optimal management of Cogan's syndrome: a multidisciplinary approach. J Multidiscip Healthc 2018; 11:1-11.

45. Radic

M, et al. Drug-induced vasculitis: a clinical and pathological review. Neth J Med 2012; 70(1): 12-7.

46. Anastasiakis

A, et al. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction. Doc Ophthalmol 2011; 123(1): 59-63.

47. Mochizuki

M, et al. for the International Workshop on Ocular Sarcoidosis Study Group: Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 2019; 0: 1-5.

48. Pasadhika

S, et al. Ocular Sarcoidosis. Clin Chest Med 2015 Dec; 36(4): 669-683.

49. Amin

SR, et al. Retinal Vasculitis, Aneurysms, and Neovascularization in Blau Syndrome JAMA Ophthalmol 2013; 131(5): 677-679.

50. Dunn

JP. Multiple-Sclerosis-Associated Uveitis Considerations for treatment of this unique patient population. Retinal Physician 2018; 15: 38-40.

51. Zein

G, et al. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004; 12(21:137-42.

52. Biswas

J, et al. Eales' disease - current concepts in diagnosis and management. J Ophthalmic Inflamm Infect 2013; 3: 11.

53. Biswas

J, et al. Eales disease - an update. Surv Ophthalmol 2002; 47(3): 197-214.

54. Chang

TS, et al. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Ophthalmology 1995; 102:1089-1097.

55. Samuel

MA, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology 2007; 114: 1526-1529.

56. Bajgai

P, et al. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives Clin Ophthalmol 2017; 11:1805-1817.

57. Nourinia

R, et al. Idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome associated with positive perinuclear antineutrophil cytoplasmic antibody. J Ophthalmic Vis Res 2011; 6: 330-333.

58. Kurz

DE, et al. Idiopathic retinal vasculitis, aneurysms, and neuroretinitis in a patient with antiphospholipid syndrome. Arch Ophthalmol 2012; 130: 257-258.

59. Tran

TH, et al. Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthlamol 2003; 87: 79-83,

60. Wimmersberger

Y,

et

al.

VZV retinal vasculitis without systemic infection: diagnosis and monitoring with quantitative Polymerase Chain Reaction. Int

Ophthalmol 2010; 30(1): 73-5.

61. Nagel

MA, et al. Developments in Varicella Zoster Virus Vasculopathy. Curr Neurol Neurosci Rep 2016; 16(2): 12.

62. Nagel

MA, et al. The varicella zoster virus vasculopathies Clinical, CSF, imaging, and virologic features Neurology 2008: 70(11): 853-860.

63. Fardeau

C et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 2002; 134:196-203.

64. Morgan

CM, et al. Branch retinal artery occlusion associated with recurrent toxoplasmic retinochoroiditis. Arch Ophthalmol 1987; 105: 130-1.

65. Tandon

R, et al. Toxoplasmic papillitis with central retinal artery occlusion.

Can J Ophthalmol 1995; 30: 374-6.

66. Gentile

RC, et al. Retinal vascular occlusions complicating acute toxoplasmic retinochoroiditis. Can J Ophthalmol 1997; 32: 354-8.

67. Suzuki

J, et al. Comparison of patients with ocular tuberculosis in the 1990s and 2000s Jpn J Ophthalmol 2010; 54(1): 19-23.

68. Leng

T, et al. Retinal vascular tumor and periferal retinal vasculitis in the setting of systemic tuberculosis. Ophthalmic Surg Lasers Imaging 2009; 40(4): 409-12.

69. Gupta

V, et al. Intraocular Tuberculosis - An Update Surv of Ophthalmol 2007; 52(6): 561-587.

70. Anderson

AM, et al. Syphilitic frosted branch angiitis with anterior uveitis in a patient with a new HIV diagnosis. Lancet Infect Dis 2009; 9(7): 453.

71. Yokoi

M, et al. Retinal vasculitis due to secondary syphilis. Jpn J Ophthalmol 2004; 48(1): 65-7.

72. Smith

JL, et al. Retinal vasculitis in Lyme borreliosis. J Clin Neuroophthalmol 1991; 11(1): 7-15.

73. Mikkilä

HO,

et al. The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology 2000; 107(3): 581-7.

74. Kyrieleis

W. Ueber atypische

gefasstuberkulose

der

Netzhaut: Periarteritis

nodosa tubercu-losa. Arch Augenheilk 1933; 107:182.

75. Francés-Munoz

E,

et

al. Kyrieleis' vasculitis in acute retinal necrosis. Clin Ophthalmol 2010; 4: 837-838.

76. Krishnamurthy

R, et al. Atypical presentation of syphilitic uveitis associated with Kyrieleis plaques. Br J Ophthalmol 2008; 92(8): 1152-3.

77. Pichi

F, et al. New appraisals of Kyrieleis plaques: a multimodal imaging study. Br J Ophthalmol 2017; 101: 316-321.

78. Marzanoa

AV, et al. Skin involvement in cutaneous and systemic vasculitis - A Review. Autoimmun

Rev

2013; 12: 467-476.

79. Edgar

NR, et al. Recurrent Aphthous Stomatitis: A Review. J Clin Aesthet Dermatol 2017; 10(3): 26-36.

80. Tarakji

B, et al. Guideline for the Diagnosis and Treatment of Recurrent Aphthous Stomatitis for Dental Practitioners. J Int

Oral

Health 2015; 7(5): 74-80.

81. Bougea

A, Anagnostou E,

Spandideas

N,

Triantafyllou

N,

Kararizou

E. An update of neurological manifestations of vasculitis and connective tissue diseases Einstein (Sao Paulo). 2015 Oct-Dec; 13(4): 627-635.

82. Verztman

L. Polyarteritis nodosa. Clin. Rheum Dis 1980; 6: 297-317.

83. Bossuyt

X, et al. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatology 2017; 13: 683-692.

84. Jeon

S, Lee WK. Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythematosus and anti-phospholipid syndrome. Lupus 2012; 21(3): 335-7.

Levelezési cím

c Dohán

Judit, SE, Szemészeti Klinika, 1085 Budapest, Mária u. 39. mail: kodoju@gmail.com

\222;